Seoul, South Korea

Jae Gal Shim

This inventor holds 1 USPTO granted patent. Top assignees: National Cancer Center, National Institute for Korean Medicine Development. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jae Gal Shim: Innovator in Lung Cancer Treatment

Introduction

Jae Gal Shim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the area of cancer treatment. His innovative work has the potential to impact the lives of many individuals affected by lung cancer.

Latest Patents

Jae Gal Shim holds a patent for a composition aimed at preventing or treating lung cancer. The patent, titled "Composition for Preventing or Treating Lung Cancer, Comprising a Compound Isolated from Cephalotaxus Extract as an Active Ingredient," showcases his dedication to advancing medical science. He has 1 patent to his name, reflecting his commitment to innovation in healthcare.

Career Highlights

Throughout his career, Jae Gal Shim has worked with esteemed organizations such as the National Institute for Korean Medicine Development and the National Cancer Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jae Gal Shim has collaborated with notable colleagues, including Kyung Sil Yoon and Dong Hoon Shin. These partnerships have further enriched his research and development efforts, fostering an environment of innovation and discovery.

Conclusion

Jae Gal Shim's work in developing treatments for lung cancer exemplifies the spirit of innovation in the medical field. His contributions are paving the way for new therapeutic options that could benefit countless patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…